Capital World Investors’s AbbVie ABBV Stock Holding History

Capital World Investors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.45B	Buy	15,841,367 +2,769,923	+21%	+$614M	0.47%	55
2025 Q4	$2.99B	Buy	13,071,444 +6,736,161	+106%	+$1.53B	0.41%	66
2025 Q3	$1.47B	Sell	6,335,283 -139,297	-2%	-$28.4M	0.2%	117
2025 Q2	$1.2B	Sell	6,474,580 -9,691,073	-60%	-$1.8B	0.17%	126
2025 Q1	$3.39B	Sell	16,165,653 -244,624	-1%	-$47.6M	0.55%	53
2024 Q4	$2.92B	Buy	16,410,277 +959,242	+6%	+$176M	0.44%	61
2024 Q3	$3.05B	Buy	15,451,035 +5,167,456	+50%	+$964M	0.47%	59
2024 Q2	$1.76B	Buy	10,283,579 +5,910,395	+135%	+$979M	0.29%	93
2024 Q1	$796M	Buy	4,373,184 +3,120,310	+249%	+$538M	0.13%	154
2023 Q4	$194M	Hold	1,252,874	–	–	0.03%	278
2023 Q3	$187M	Hold	1,252,874	–	–	0.04%	275
2023 Q2	$169M	Hold	1,252,874	–	–	0.03%	284
2023 Q1	$200M	Sell	1,252,874 -1,252,146	-50%	-$191M	0.04%	275
2022 Q4	$405M	Buy	2,505,020 +1,434,596	+134%	+$220M	0.09%	201
2022 Q3	$144M	Buy	+1,070,424	New	+$154M	0.03%	301
2019 Q4	–	Sell	-7,601,408	Closed	-$576M	–	516
2019 Q3	$576M	Sell	7,601,408 -335,524	-4%	-$23M	0.14%	151
2019 Q2	$577M	Sell	7,936,932 -9,792,695	-55%	-$770M	0.14%	151
2019 Q1	$1.43B	Sell	17,729,627 -1,593,555	-8%	-$130M	0.35%	75
2018 Q4	$1.78B	Sell	19,323,182 -6,035,843	-24%	-$531M	0.48%	57
2018 Q3	$2.4B	Buy	25,359,025 +10,858,432	+75%	+$1.03B	0.58%	46
2018 Q2	$1.34B	Sell	14,500,593 -2,603,223	-15%	-$254M	0.29%	92
2018 Q1	$1.62B	Buy	17,103,816 +1,119,813	+7%	+$123M	0.36%	76
2017 Q4	$1.55B	Buy	15,984,003 +782,999	+5%	+$73.8M	0.34%	78
2017 Q3	$1.35B	Buy	15,201,004 +11,770,004	+343%	+$896M	0.31%	86
2017 Q2	$249M	Buy	3,431,000 +1,008,000	+42%	+$67.8M	0.06%	208
2017 Q1	$158M	Sell	2,423,000 -2,839,592	-54%	-$179M	0.04%	243
2016 Q4	$330M	Sell	5,262,592 -1,500,000	-22%	-$91.6M	0.08%	187
2016 Q3	$426M	Buy	6,762,592 +597,000	+10%	+$38.6M	0.11%	162
2016 Q2	$380M	Buy	6,165,592 +1,365,592	+28%	+$83.2M	0.1%	173
2016 Q1	$274M	Buy	4,800,000 +3,200,000	+200%	+$178M	0.08%	201
2015 Q4	$94.8M	Hold	1,600,000	–	–	0.03%	287
2015 Q3	$87.1M	Sell	1,600,000 -1,520,000	-49%	-$98.9M	0.03%	297
2015 Q2	$210M	Sell	3,120,000 -4,506,934	-59%	-$294M	0.06%	245
2015 Q1	$446M	Sell	7,626,934 -9,543,066	-56%	-$577M	0.12%	172
2014 Q4	$1.12B	Buy	17,170,000 +2,465,000	+17%	+$155M	0.3%	81
2014 Q3	$849M	Sell	14,705,000 -5,015,000	-25%	-$278M	0.24%	103
2014 Q2	$1.11B	Sell	19,720,000 -2,424,032	-11%	-$127M	0.31%	86
2014 Q1	$1.14B	Sell	22,144,032 -352,500	-2%	-$17.8M	0.32%	84
2013 Q4	$1.19B	Hold	22,496,532	–	–	0.33%	85
2013 Q3	$1.01B	Buy	22,496,532 +2,668,732	+13%	+$118M	0.31%	91
2013 Q2	$820M	Buy	+19,827,800	New	+$867M	0.27%	99

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors's ABBV Position: Q1 2026 in Review

Capital World Investors increased its AbbVie (ABBV) stake by 21% in Q1 2026, buying an estimated $614M and bringing the position to 15,841,367 shares worth $3.45B. The position accounts for 0.47% of the portfolio, ranked #55.

Capital World Investors first reported a position in ABBV in Q2 2013 and has held it in 41 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Capital World Investors held 15,841,367 shares of AbbVie worth $3.45B as of Q1 2026.
Capital World Investors bought 2,769,923 AbbVie shares in Q1 2026, an estimated $614M.
AbbVie made up 0.47% of Capital World Investors's portfolio in Q1 2026, its #55 holding.
Capital World Investors first reported a position in AbbVie in Q2 2013 and has held it in 41 quarters since.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.